Access Simplified
One Goal: Access for Every Resident Prescribed INGREZZA (valbenazine) capsules or INGREZZA SPRINKLE (valbenazine) capsules
Learn more about prescribing, financial support,
and resources tailored for Long-Term Care.
Actor portrayals
Know your INGREZZA prescribing options.
Here’s how to start your residents on INGREZZA:
Service Request Form
Treatment Form
Download and fax the INGREZZA Service Request Form or the treatment form, both of which enroll residents in the Neurocrine Access Support program
CoverMyMeds
Step-by-step instructions to initiate treatment and enroll patients in the Neurocrine Access Support program by using the INGREZZA digital treatment form. CoverMyMeds can also provide support for prior authorization (PA) requests
ePrescribe
You can ePrescribe to our dedicated network of pharmacies
Neurocrine Access Support is here to help eligible residents get access to their INGREZZA prescription
There are a variety of access support tools available to you and your residents.
- ~90% of residents pay $10 or less out of pocket for INGREZZA.1,*
- INGREZZA coverage is approved for more than 8 in 10 residents nationwide2,†
*Based on National Drug Code (NDC) as of February 2025.1
†Based on NDC as of July 2025.2
Assistance may be available for residents without insurance coverage through the Patient Assistance Program.
With our Patient Assistance Program, we help residents by providing INGREZZA at no cost for residents who have no insurance, those with insurance but lacking prescription coverage for INGREZZA, or who demonstrate a qualifying financial need.‡
‡Additional terms and conditions apply.
Download the patient assistance application.
We have a dedicated team of RPAMs who can provide onsite access support at your facility.
Connect to your Regional Patient Access Manager (RPAM) about resident access and related coverage issues
- Payer coverage issues
- PA process
- Patient Assistance Program
- Training and education
Third party trademarks are property of their respective owners.
References
1. Data on file; 09/2024 through 02/2025. Neurocrine Biosciences, Inc. 2. Data on file; 01/2025 through 05/2025. Neurocrine Biosciences, Inc.
